Results
74,396 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Sibold William JohnDirector, President and CEO |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $116K 215 sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $116K 215 sh |
| Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner |  HNGEHinge Health, Inc.Derivative conversion · 10b5-1 plan | C | — 150.0K sh | Sep 11, 2026 traded Sep 10, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $184K 347 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $69K 131 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $87K 160 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $196K 368 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $371K 687 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $652K 1,202 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 3 | Tak Paul PeterDirector, Chief Executive Officer |  CADLCandel Therapeutics, Inc.Option exercise · 10b5-1 plan | M | — 125.0K sh | Sep 11, 2026 traded Sep 10, 2026 |
| 3 | Brosius MarkEVP & Chief Mfg and Supply Cha |  ISRGINTUITIVE SURGICAL INCOpen-market sale · 10b5-1 plan | SELL | $9,145 25 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 3 | Sullivan Christopher RyanChief Financial Officer |  AVTXAvalo Therapeutics, Inc.Option exercise · 10b5-1 plan | M | $82K 10.2K sh | Sep 11, 2026 traded Sep 10, 2026 |
| 3 | Brosius MarkEVP & Chief Mfg and Supply Cha | ISRGINTUITIVE SURGICAL INC Open-market sale · 10b5-1 plan | SELL | $7,996 23 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 1 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $117K 218 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 1 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $66K 120 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 1 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $86K 160 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 1 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $57K 106 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 1 | Arora TarunChief Accounting Officer |  RNGRingCentral, Inc.Open-market sale · 10b5-1 plan | SELL | $190K 2,679 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 1 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $199K 368 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 1 | Arora TarunChief Accounting Officer | RNGRingCentral, Inc. Open-market sale · 10b5-1 plan | SELL | $104K 1,493 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 0 | Tsao DavidDirector, Chief Technology Officer |  BLLNBillionToOne, Inc.Option exercise · 10b5-1 plan | M | $28K 10.0K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 0 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Gift · 10b5-1 plan | G | — 45.0K sh | Sep 11, 2026 traded Sep 10, 2026 |
| 0 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Derivative conversion · 10b5-1 plan | C | — 145.0K sh | Sep 11, 2026 traded Sep 10, 2026 |
| 0 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Derivative conversion · 10b5-1 plan | C | — 145.0K sh | Sep 11, 2026 traded Sep 10, 2026 |
| 0 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Option exercise · 10b5-1 plan | M | $28K 10.0K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 0 | Sullivan Christopher RyanChief Financial Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 10.2K sh | Sep 11, 2026 traded Sep 10, 2026 |
| 0 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $32K 60 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 0 | Azar Samak LChief Legal Officer |  GFSGLOBALFOUNDRIES Inc.Open-market sale · 10b5-1 plan | SELL | $15K 335 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 51 | Jubran SamiEVP Chief Finance Officer |  ZIMZIM Integrated Shipping Services Ltd.Open-market sale | SELL | $55K 1,824 sh | Sep 10, 2026 traded Sep 8, 2026 |
| 48 | Jubran SamiEVP Chief Finance Officer | ZIMZIM Integrated Shipping Services Ltd. Open-market sale | SELL | $36K 1,196 sh | Sep 10, 2026 traded Sep 8, 2026 |
| 46 |  Gilbert Ray Cisneros, Jr.DSelf |  INTUINTUIT INC.Purchase | BUY | $1,001 – $15K | Sep 10, 2026 traded Aug 18, 2026 |
| 46 | Gu PaulDirector, Chief Executive Officer |  UPSTUpstart Holdings, Inc.Open-market purchase | BUY | $1.28M 50.0K sh | Sep 10, 2026 traded Sep 10, 2026 |
| 44 | Intrator Michael NDirector, CEO and President, 10% Owner |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $3.08M 29.9K sh | Sep 10, 2026 traded Sep 8, 2026 |
| 43 | Gilbert Ray Cisneros, Jr.DSelf |  SNOWSnowflake Inc.Purchase | BUY | $1,001 – $15K | Sep 10, 2026 traded Aug 7, 2026 |
| 42 | Butcher StephanieSenior Managing Director |  IVZInvesco Ltd.Open-market sale | SELL | $1.46M 45.1K sh | Sep 10, 2026 traded Sep 9, 2026 |
| 42 | Williams Ashley HDirector |  TFSLTFS Financial CORPOpen-market sale | SELL | $173K 10.0K sh | Sep 10, 2026 traded Sep 8, 2026 |
| 42 | Morais Silvio JoseDirector |  STNEStoneCo Ltd.Open-market sale | SELL | $208K 21.0K sh | Sep 10, 2026 traded Sep 2, 2026 |
| 42 | Senn AndrewPresident, Growth & Innovation |  ITGRInteger Holdings CorpOpen-market sale | SELL | $1.19M 9,408 sh | Sep 10, 2026 traded Sep 8, 2026 |
| 42 | Gilbert Ray Cisneros, Jr.DSelf |  NETCloudflare, Inc.Partial sale | SELL | $1,001 – $15K | Sep 10, 2026 traded Aug 18, 2026 |
| 42 | Parish Douglas J.Director |  BWBBridgewater Bancshares IncOpen-market sale | SELL | $86K 4,000 sh | Sep 10, 2026 traded Sep 9, 2026 |
| 41 | Gilbert Ray Cisneros, Jr.DSelf |  NVDANVIDIA CORPPartial sale | SELL | $1,001 – $15K | Sep 10, 2026 traded Aug 18, 2026 |